BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...

Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

AI-driven enterprise tech startup SpotDraft has raised $54 Mn in its Series B funding round led by Vertex Growth and Trident ...

Corporate Venture Capital (CVC) investment is an increasingly used strategic tool that enables large corporations to make minority investments ...

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...

Crude futures extend their recovery from last week's lows to three sessions as the market navigates different scenarios for ...

ABC News’ Alexis Christoforous reports on what Fed Chair Jerome Powell is telling lawmakers about a “strong overall” economy.

Real-time index price for TSX Venture Composite Index (JX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

Real-time index price for TSX Venture Composite Index (JX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Qatar’s VC (venture capital) funding reported a remarkable 135% year-on-year rise to an all-time high of QR115mn in 2024, ...

This latest initiative raises Hitachi’s total investment in CVC to $1 billion, reinforcing its commitment to identifying and ...